Form 8-K - Current report:
SEC Accession No. 0001558370-24-016459
Filing Date
2024-12-23
Accepted
2024-12-23 16:02:12
Documents
14
Period of Report
2024-12-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20241217x8k.htm   iXBRL 8-K 51468
2 EX-10 mrns-20241217xex10.htm EX-10 74493
  Complete submission text file 0001558370-24-016459.txt   268658

Data Files

Seq Description Document Type Size
3 EX-101.SCH mrns-20241217.xsd EX-101.SCH 3254
4 EX-101.LAB mrns-20241217_lab.xml EX-101.LAB 16592
5 EX-101.PRE mrns-20241217_pre.xml EX-101.PRE 10714
16 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20241217x8k_htm.xml XML 5113
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 241573538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)